Clinical Trial

Dose Escalation Using Hypoxia-adjusted Radiotherapy

Study acronym: DE-HyART
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
DE-HyART is a phase II clinical trial aimed at understanding the effects of escalating radiation doses to hypoxic sub-volumes inherent to squamous cell head and neck cancer. The study is aimed at assessing locoregional control, feasibility, and acceptable toxicity with such a strategy.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-11; most recent amendment 2025-01-16.
Status change: Not Yet Recruiting → Recruiting 2023-10-20
Trial Details
NCT Number NCT06087614
Lead Sponsor Rajiv Gandhi Cancer Institute & Research Center, India
Collaborators: Varian, a Siemens Healthineers Company
Conditions Head and Neck Squamous Cell Carcinoma
Enrollment 124 participants
Start Date 2024-04-08
Primary Completion 2028-04 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2025-01-17